Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02194530 · ClinicalTrials.gov registry record
Reduction of Peanut Reactivity and Immune Modulation With Anti-IgE Therapy
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 11
- Enrollment target
NCT02194530 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 11 participants.
The verdict
NCT02194530 has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
Study Summary
This pilot study is will examine the pathways involved in allergic response, primarily in food allergy; specifically peanut allergy. We will also study non-allergic donors as well as patients with atopic disorders, primarily as control subjects. We believe that this study will lead to discovery of significant pathways involved in the allergic pathway that can be explored in more detail during follow-up studies in order to address mechanistic questions that cannot be answered in a pilot trial. We believe that such a pilot study represents the ideal approach to identify effective therapeutic interventions and to simultaneously better understand the underlying mechanistic properties involved in the allergy cascade. We think that this study forms the basis for a novel avenue of research into the pathogenesis of allergic pathways, a disease that is still associated with significant morbidity and mortality.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2015-03-30 |
| Est. Completion | 2016-07-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02194530
The ClinicalTrials.gov registry entry for NCT02194530 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02194530 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02194530 about?
NCT02194530 is a clinical study titled "Reduction of Peanut Reactivity and Immune Modulation With Anti-IgE Therapy". This pilot study is will examine the pathways involved in allergic response, primarily in food allergy; specifically peanut allergy. We will also study non-allergic donors as well as patients with atopic disorders, primarily as control subjects. We believe that this study will lead to discovery of s...
What is the current status of trial NCT02194530?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2015-03-30. Estimated completion is 2016-07-19.
Who is sponsoring clinical trial NCT02194530?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.